Lead Injectable Candidate
Opioid Overdose Rescue / Opioid-Induced Respiratory Depression (OIRD)
Key Facts
About OYE Therapeutics
OYE Therapeutics is developing a novel injectable drug product aimed at revolutionizing the treatment of opioid overdose and reversing general anesthesia, two areas with significant unmet medical needs. The company positions its solution as addressing the shortcomings of naloxone, such as its short duration of action and high relapse rate, while also targeting a massive $95B annual cost burden associated with overdose treatment. As a private, pre-revenue, clinical-stage biotech, OYE is seeking investment to advance its lead candidate through development for multiple clinical settings including emergency departments, EMS, and surgical centers.
View full company profileAbout OYE Therapeutics
OYE Therapeutics is developing a novel injectable drug product aimed at revolutionizing the treatment of opioid overdose and reversing general anesthesia, two areas with significant unmet medical needs. The company positions its solution as addressing the shortcomings of naloxone, such as its short duration of action and high relapse rate, while also targeting a massive $95B annual cost burden associated with overdose treatment. As a private, pre-revenue, clinical-stage biotech, OYE is seeking investment to advance its lead candidate through development for multiple clinical settings including emergency departments, EMS, and surgical centers.
View full company profile